William Jackson
Director/Board Member bei REVIVE THERAPEUTICS LTD.
Vermögen: 13 650 $ am 31.03.2024
Profil
William Jackson was the founder of Covalon Technologies Ltd.
(founded in 2004) where he held the title of Chief Operating & Financial Officer, Director from 2004 to 2013.
Mr. Jackson is also the founder of Preferred Medical Products, Inc., QuickStitch, Inc., Attwill Medical Solutions, Inc. Mr. Jackson's current job(s) include being the Chief Executive Officer & Director at Attwill Vascular Technologies LP, a Director at Revive Therapeutics, Inc., an Independent Director at MyndTec, Inc. (since 2022), and an Independent Director at Revive Therapeutics Ltd.
(since 2014).
Mr. Jackson's former job(s) include being a Director at Titan Medical, Inc. (2008-2010), Senior VP-Marketing & Business Development at Stryker Corp.
(2006), President & Secretary at KAM Capital Corp.
(2007-2008), and having a position at NatWest Equity Partners Ltd.
in 2004.
Mr. Jackson's education history includes an undergraduate degree from the University of Western Ontario (1980) and an undergraduate degree from the University of Windsor (1982).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REVIVE THERAPEUTICS LTD.
0,18% | 02.01.2024 | 650 000 ( 0,18% ) | 13 650 $ | 31.03.2024 |
MYNDTEC, INC.
-.--% | 15.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von William Jackson
| Unternehmen | Position | Beginn |
|---|---|---|
| REVIVE THERAPEUTICS LTD. | Director/Board Member | 01.01.2014 |
| MYNDTEC INC. | Director/Board Member | 11.05.2022 |
Attwill Medical Solutions, Inc.
 Attwill Medical Solutions, Inc. Pharmaceuticals: MajorHealth Technology Attwill Medical Solutions, Inc. develops and manufactures pharmaceuticals, medical devices, and biologics products. The private company is based in Lodi, WI. The company was founded by William Jackson and Attilio DiFiore, with William Jackson serving as the CEO since incorporation. | Chief Executive Officer | - |
Revive Therapeutics, Inc.
 Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The private company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Director/Board Member | - |
Attwill Vascular Technologies LP
 Attwill Vascular Technologies LP Internet Software/ServicesTechnology Services Attwill Vascular Technologies LP operates as a technology platform. The private company is based in Lodi, WI and has subsidiaries in the United States. The CEO of the company is William Jackson. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von William Jackson
| Unternehmen | Position | Ende |
|---|---|---|
| COVALON TECHNOLOGIES LTD. | Founder | 01.01.2013 |
| TITAN MEDICAL INC. | Director/Board Member | 08.06.2010 |
KAM Capital Corp.
 KAM Capital Corp. Financial ConglomeratesFinance KAM Capital Corp. is a capital pool company engaged in the identification of assets or businesses with a view to complete a qualifying transaction. It is based in Toronto, ON. | President | 06.05.2008 |
| STRYKER CORPORATION | Corporate Officer/Principal | 01.01.2006 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Ausbildung von William Jackson
| University of Western Ontario | Undergraduate Degree |
| University of Windsor | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| STRYKER CORPORATION | Health Technology |
| COVALON TECHNOLOGIES LTD. | Health Technology |
| TITAN MEDICAL INC. | Health Technology |
| MYNDTEC INC. | Health Technology |
| REVIVE THERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
KAM Capital Corp.
KAM Capital Corp. Financial ConglomeratesFinance KAM Capital Corp. is a capital pool company engaged in the identification of assets or businesses with a view to complete a qualifying transaction. It is based in Toronto, ON. | Finance |
Preferred Medical Products, Inc.
 Preferred Medical Products, Inc. Medical SpecialtiesHealth Technology Part of Kimberly-Clark Corp., Preferred Medical Products, Inc. is a manufacturer of disposable pain therapy products. The private company is based in Thorold, Canada. Preferred Medical Products was acquired by Ballard Medical Products on September 04, 1996 for $5 million. The Canadian company was founded by William Jackson. | Health Technology |
QuickStitch, Inc.
 QuickStitch, Inc. Miscellaneous Commercial ServicesCommercial Services Quick Stitch Ltd. provides alteration services for various types of clothing including wedding and bridal gowns, menswear, suits, and work wear. The American company was founded by William Jackson. | Commercial Services |
Revive Therapeutics, Inc.
Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The private company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Health Technology |
Attwill Medical Solutions, Inc.
Attwill Medical Solutions, Inc. Pharmaceuticals: MajorHealth Technology Attwill Medical Solutions, Inc. develops and manufactures pharmaceuticals, medical devices, and biologics products. The private company is based in Lodi, WI. The company was founded by William Jackson and Attilio DiFiore, with William Jackson serving as the CEO since incorporation. | Health Technology |
Attwill Vascular Technologies LP
Attwill Vascular Technologies LP Internet Software/ServicesTechnology Services Attwill Vascular Technologies LP operates as a technology platform. The private company is based in Lodi, WI and has subsidiaries in the United States. The CEO of the company is William Jackson. | Technology Services |
